Incretin mimetics provide a pharmacological stimulus to insulin secretion and elicit other GLP-1-receptor-mediated activity as drugs, but are typically introduced at much higher concentrations compared with physiological levels of GLP-1 [65, 66]
But if you add only 1mL, that same 10 units now contains 0.5mg, double the dose
In case of long-term treatment, the dose should be reduced progressively to avoid the aforementioned complications
Chen D, Chu B, Yang X, Liu Z, Jin Y, Kon N, Rabadan R, Jiang X et al (2021) iPLA2-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimers Disease
What Is Vitamin IV Therapy